Related Experiment Video
Updated: Jan 13, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Evaluation of myocardial function and structure in valvular heart disease: what is needed for risk assessment and
Erwan Donal1, Marina Petersen Saadi1, Marc Dweck2
1University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, 2 rue Henri le Guilloux, 35033, Rennes F-35000, France.
Insights
Valvular heart disease (VHD) is a myocardial disease. New imaging tools detect heart muscle injury early, enabling better management focused on the ventricle, not just the valve.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Biomedical Engineering
Background:
- Traditional valvular heart disease (VHD) assessment focuses on valve function, often missing early myocardial injury.
- Emerging evidence classifies VHD as a myocardial disease, where ventricular response significantly impacts outcomes.
- Current methods may fail to detect dysfunction until advanced stages.
Purpose of the Study:
- To redefine VHD assessment through a myocardium-first approach.
- To highlight advanced imaging tools for early detection of myocardial dysfunction in VHD.
- To propose a new management strategy centered on myocardial protection.
Main Methods:
- Review of contemporary evidence and state-of-the-art imaging techniques.
- Focus on specific myocardial strain parameters: LV global longitudinal strain (LV-GLS), RV strain with RV-PA coupling, and LA reservoir strain.
- Integration of cardiac magnetic resonance (CMR) parameters (native T1, ECV, LGE) and next-generation technologies (CT-ECV, molecular imaging, AI).
Main Results:
- A triad of strain measures (LV-GLS, RV-PA coupling, LA strain) detects myocardial injury early and improves prognostic accuracy.
- CMR identifies diffuse and focal fibrosis, crucial for understanding remodeling.
- Advanced technologies like CT-ECV, molecular imaging, and AI offer scalable and personalized risk assessment.
Conclusions:
- VHD management should prioritize myocardial health, shifting focus from valve correction to ventricle protection.
- A serial, multiparametric, AI-enhanced strategy utilizing advanced imaging can guide interventions during the optimal therapeutic window.
- This myocardium-centric approach is essential for preserving cardiac function in VHD patients.
Abstract:
Valvular heart disease (VHD) is traditionally assessed through gradients, regurgitant volumes, and ejection fraction-but these valve-centric indices miss the earliest and most decisive signal: myocardial injury. Contemporary evidence shows that VHD is a myocardial disease, where outcomes are driven far more by the ventricle's biological response than by the valve lesion itself. This state-of-the-art review redefines VHD through a myocardium-first lens, highlighting tools that expose dysfunction long before conventional thresholds fail. A focused triad-LV global longitudinal strain (LV-GLS), RV strain with RV-PA coupling, and LA reservoir strain-detects injury at its inception and sharply improves prognostic precision. Cardiac magnetic resonance adds mechanistic depth through native T1, extracellular volume, and late gadolinium enhancement, identifying diffuse and focal fibrosis that dictate timing and reversibility of remodelling. Next-generation technologies extend this paradigm: CT-derived ECV as a scalable fibrosis surrogate, molecular imaging revealing active calcification and fibro-inflammation, and AI-driven models that fuse imaging, biomarkers, and clinical variables into personalized risk trajectories. We propose a serial, multiparametric, AI-enhanced strategy centred on myocardial protection-using LV-GLS tracking, RV-PA coupling, atrial mechanics, and fibrosis imaging to intervene during the true therapeutic window. This review positions a simple but transformative concept: managing VHD means managing the myocardium. Adopting this shift is essential for preserving cardiac health-not merely correcting valve anatomy.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Dysrhythmias V: Evaluating Dysrhythmias
Mitral Stenosis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis III: Medical Management

